tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Inventiva SA (FR:IVA)
:IVA
France Market
IVA
Inventiva
RESEARCH TOOLSreports

Inventiva (IVA) Stock News & Sentiment

Compare
20 Followers
Positive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
2M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
4M ago
IVA
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
Premium
Ratings
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
4M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
5M ago
IVA
Inventiva’s Strategic Positioning and Promising Developments Drive Buy Rating
Premium
Ratings
Inventiva’s Strategic Positioning and Promising Developments Drive Buy Rating
6M ago
IVA
Inventiva’s Strong Financial Position and Promising Phase 3 Trial Drive Buy Rating
Premium
Ratings
Inventiva’s Strong Financial Position and Promising Phase 3 Trial Drive Buy Rating
6M ago
IVA
Inventiva’s Lanifibranor: A Promising Investment in the MASH Space with Strong Phase III Progress and Financial Backing
Premium
Ratings
Inventiva’s Lanifibranor: A Promising Investment in the MASH Space with Strong Phase III Progress and Financial Backing
8M ago
IVA
More FR:IVA News >

IVA News on the Web

Jefferies Reaffirms Their Buy Rating on Inventiva (0RNK)
TipRanks News
Bullish
Inventiva initiated with an Overweight at Barclays
TipRanks News
Bullish
Inventiva initiated with an Outperform at Leerink
TipRanks News
Bullish
Institutional investors are Inventiva S.A.'s (EPA:IVA) biggest bettors and were rewarded after last week's €57m market cap gain
Simply Wall St
Bullish
Inventiva upgraded to Buy from Neutral at UBS
TipRanks News
Bullish
Aligos Therapeutics initiated with a Buy at UBS
TipRanks News
Neutral
The Price Is Right For Inventiva S.A. (EPA:IVA) Even After Diving 30%
Simply Wall St
Neutral
Revenue Downgrade: Here's What Analysts Forecast For Inventiva S.A. (EPA:IVA)
Simply Wall St
Neutral

News Score - Last 7 Days

Positive
FR:IVA
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:IVA’s Media Buzz Sentiment?
2 articles about FR:IVA were published this week. In an average week, 1.5 articles are published.
    What is FR:IVA’s weekly average amount of articles?
    In an average week, 1.5 articles about FR:IVA are published.
      What is FR:IVA’s News Sentiment?
      100% of articles about FR:IVA were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        IMAImageneBio
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        QNCXQuince Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week